
|Articles|November 15, 2002
DTC Advertising: Friend or Foe?
Direct-to-consumer advertising in U.S. healthcare is at both a zenith and crossroads where capitalism meets the ethical practice of medicine. DTC spending has never been higher, rising steadily since the U.S. Food and Drug Administration approved the tactic in 1997.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
5

















